Express Pharma

USFDA concludes GMP inspection at Dr Reddy’s R&D centre

The inspection was conducted from September 16 to September 20, 2024. The inspection closed with zero observations

0 1,451

The United States Food & Drug Administration (USFDA) completed a routine Good Manufacturing Practice (GMP) inspection at Dr Reddy’s Laboratories’ R&D centre  (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad. 

The inspection was conducted from September 16 to September 20, 2024. The inspection closed with zero observations.

- Advertisement -

Leave A Reply

Your email address will not be published.